A pharmacist’s search for one patient’s savings became a business McKesson bought for $600 million upfront. Its useful insight: finding a cheaper medicine is only half the job.
The oncology business inside McKesson turns routine patient records into research material. Its advantage begins where the treatment happens - and its hardest work begins where the tidy fields end.